Concepedia

An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

Dana Madorsky-Feldman, Miri Sklair‐Levy, Tamar Perri, Yael Laitman, Shani Paluch–Shimon, Rita K. Schmutzler, Kerstin Rhiem, Jenny Lester, Beth Y. Karlan, Christian F. Singer,

Breast Cancer Research and Treatment · 2016 · 38 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality

Susan M. Domchek · JAMA · 2010 · 1.5K citations · Full text

, , +17

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Ian Jacobs, Usha Menon, Andy Ryan et al. · The Lancet · 2015 · 1.1K citations · Full text

, , +14

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a <i>BRCA1</i> or <i>BRCA2</i> Mutation

Amy Finch, Jan Lubiński, Pål Møller et al. · Journal of Clinical Oncology · 2014 · 655 citations · Full text

, , +17

Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

Christopher C. Riedl, Nikolaus Luft, Clemens Bernhart et al. · Journal of Clinical Oncology · 2015 · 303 citations · Full text

, , +17

Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging

Sylvia K. Plevritis, Allison W. Kurian, Bronislava M. Sigal et al. · JAMA · 2006 · 260 citations · Full text

, , +17